Alterations to surfactant precede physiological deterioration during high tidal volume ventilation

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 294, Issue 5, 2008, Pages

  Maruscak, Adam A ^a   Vockeroth, Daniel W ^a   Girardi, Brandon ^a   Sheikh, Tanya ^a   Possmayer, Fred ^a   Lewis, James F ^a   Veldhuizen, Ruud A W ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Biophysical activity; Mechanical ventilation; Ventilation induced lung injury

Indexed keywords

SURFACTANT; CHOLESTEROL; INTERLEUKIN 6; OXYGEN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD OXYGENATION; BREATHING RATE; CONTROLLED STUDY; LUNG INJURY; LUNG VENTILATION; MALE; NONHUMAN; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RAT; TIDAL VOLUME; ANIMAL; BLOOD; BLOOD PRESSURE; DISEASE MODEL; LUNG; LUNG DISEASE; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD PRESSURE; CHOLESTEROL; DISEASE MODELS, ANIMAL; INTERLEUKIN-6; LUNG; LUNG DISEASES; MALE; OXYGEN; POSITIVE-PRESSURE RESPIRATION; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; RATS; RATS, SPRAGUE-DAWLEY; TIDAL VOLUME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 45849124206     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00528.2007     Document Type: Article

References (39)

1. Bailey TC, Maruscak AA, Petersen A, White S, Lewis JF, Veldhuizen RA. Physiological effects of oxidized exogenous surfactant in vivo: effects of high tidal volume and surfactant protein A. Am J Physiol Lung Cell Mol Physiol 291: L703-L709, 2006.
2. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
3. Brower RG, Fessler HE. Mechanical ventilation in acute lung injury and acute respiratory distress syndrome. Clin Chest Med 21: 491-510, viii, 2000.
4. Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 342: 1301-1308, 2000.
5. Brower RG, Shanholtz CB, Fessler HE, Shade DM, White P, Wiener CM, Teeter JG, Dodd-o JM, Almog Y, Piantadosi S. Prospective, randomized, controlled clinical trial comparing traditional vs. reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med 27: 1492-1498, 1999.
6. Cockshutt AM, Weitz J, Possmayer F. Pulmonary surfactant- associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry 29: 8424-8429, 1990.
7. Da Silva K, McCaig LA, Veldhuizen RA, Possmayer F. Protein inhibition of surfactant during mechanical ventilation of isolated rat lungs. Exp Lung Res 31: 745-758, 2005.
8. Duck-Chong CG. A rapid sensitive method for determining phospholipid phosphorus involving digestion with magnesium nitrate. Lipids 14: 492-497, 1979.
9. Edwards YS. Stretch stimulation: its effects on alveolar type II cell function in the lung. Comp Biochem Physiol A Mol Integr Physiol 129: 245-260, 2001.
10. Frank JA, Wray CM, McAuley DF, Schwendener R, Matthay MA. Alveolar macrophages contribute to alveolar barrier dysfunction in ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 291: L1191-L1198, 2006.
11. Goerke J. Pulmonary surfactant: functions and molecular composition. Biochim Biophys Acta 1408: 79-89, 1998.
12. Gross NJ, Narine KR. Surfactant subtypes of mice: metabolic relationships and conversion in vitro. J Appl Physiol 67: 414-421, 1989.
13. Gunasekara L, Schurch S, Schoel WM, Nag K, Leonenko Z, Haufs M, Amrein M. Pulmonary surfactant function is abolished by an elevated proportion of cholesterol. Biochim Biophys Acta 1737: 27-35, 2005.
14. Gunther A, Siebert C, Schmidt R, Ziegler S, Grimminger F, Yabut M, Temmesfeld B, Walmrath D, Morr H, Seeger W. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 153: 176-184, 1996.
15. Haagsman HP, White RT, Schilling J, Lau K, Benson BJ, Golden J, Hawgood S. Studies of the structure of lung surfactant protein SP-A. Am J Physiol Lung Cell Mol Physiol 257: L421-L429, 1989.
16. Holm BA, Enhorning G, Notter RH. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem Phys Lipids 49: 49-55, 1988.
17. Keating E, Rahman L, Francis J, Petersen A, Possmayer F, Veldhuizen R, Petersen NO. Effect of cholesterol on the biophysical and physiological properties of a clinical pulmonary surfactant. Biophys J 93: 1391-1401, 2007.
18. Kobayashi T, Ohta K, Tashiro K, Nishizuka K, Chen WM, Ohmura S, Yamamoto K. Dextran restores albumin-inhibited surface activity of pulmonary surfactant extract. J Appl Physiol 86: 1778-1784, 1999.
19. Leonenko Z, Gill S, Baoukina S, Monticelli L, Doehner J, Gunasekara L, Felderer F, Rodenstein M, Eng LM, Amrein M. An elevated level of cholesterol impairs self-assembly of pulmonary surfactant into a functional film. Biophys J 93: 674-683, 2007.
20. Lewis JF, Veldhuizen R. The role of exogenous surfactant in the treatment of acute lung injury. Annu Rev Physiol 65: 613-642, 2003.
21. Lewis JF, Veldhuizen RA. The future of surfactant therapy during ALI/ARDS. Semin Respir Crit Care Med 27: 377-388, 2006.
22. Nicholas TE, Barr HA. The release of surfactant in rat lung by brief periods of hyperventilation. Respir Physiol 52: 69-83, 1983.
23. Nitta K, Kobayashi T. Impairment of surfactant activity and ventilation by proteins in lung edema fluid. Respir Physiol 95: 43-51, 1994.
24. Panda AK, Nag K, Harbottle R, Rodriguez-Capote K, Veldhuizen RAW, Petersen N, Possmayer F. Effect of acute lung Injury on structure and function of pulmonary surfactant films. Am J Respir Cell Mol Biol 30: 641-650, 2003.
25. Possmayer F, Nag K, Rodriguez K, Qanbar R, Schurch S. Surface activity in vitro: role of surfactant proteins. Comp Biochem Physiol A Mol Integr Physiol 129: 209-220, 2001.
26. Pugin J, Dunn I, Jolliet P, Tassaux D, Magnenat JL, Nicod LP, Chevrolet JC. Activation of human macrophages by mechanical ventilation in vitro. Am J Physiol Lung Cell Mol Physiol 275: L1040-L1050, 1998.
27. Robertson B. Background to neonatal respiratory distress syndrome and treatment with exogenous surfactant. Dev Pharmacol Ther 13: 159-163, 1989.
28. Schurch S, Bachofen H, Goerke J, Possmayer F. A captive bubble method reproduces the in situ behavior of lung surfactant monolayers. J Appl Physiol 67: 2389-2396, 1989.
29. Seeger W, Grube C, Gunther A, Schmidt R. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J 6: 971-977, 1993.
30. Tremblay LN, Slutsky AS. Ventilator-induced injury: from barotrauma to biotrauma. Proc Assoc Am Physicians 110: 482-488, 1998.
31. Veldhuizen RA, Welk B, Harbottle R, Hearn S, Nag K, Petersen N, Possmayer F. Mechanical ventilation of isolated rat lungs changes the structure and biophysical properties of surfactant. J Appl Physiol 92: 1169-1175, 2002.
32. Veldhuizen RA, Yao L, Lewis JF. An examination of the different variables affecting surfactant aggregate conversion in vitro. Exp Lung Res 25: 127-141, 1999.
33. Veldhuizen RAW, Marcou J, Yao LJ, McCaig L, Ito Y, Lewis JF. Alveolar surfactant aggregate conversion in ventilated normal and injured rabbits. Am J Physiol Lung Cell Mol Physiol 270: L152-L158, 1996.
34. Veldhuizen RAW, Tremblay LN, Govindarajan A, Rozendaal BAWM, Haagsman HP, Slutsky AS. Pulmonary surfactant is altered during mechanical ventilation of isolated rat lung. Crit Care Med 28: 2545-2551, 2000.
35. Venkitaraman AR, Baatz JE, Whitsett JA, Hall SB, Notter RH. Biophysical inhibition of synthetic phospholipid-lung surfactant apoprotein admixtures by plasma proteins. Chem Phys Lipids 57: 49-57, 1991.
36. Verbrugge SJ, Bohm SH, Gommers D, Zimmermann LJ, Lachmann B. Surfactant impairment after mechanical ventilation with large alveolar surface area changes and effects of positive end-expiratory pressure. Br J Anaesth 80: 360-364, 1998.
37. Verbrugge SJ, Lachmann B. Mechanisms of ventilation-induced lung injury: physiological rationale to prevent it. Monaldi Arch Chest Dis 54: 22-37, 1999.
38. Wright JR, Dobbs LG. Regulation of pulmonary surfactant secretion and clearance. Annu Rev Physiol 53: 395-414, 1991.
39. Yu S, Harding PG, Smith N, Possmayer F. Bovine pulmonary surfactant: chemical composition and physical properties. Lipids 18: 522-529, 1983.